March 18 Rich Pharmaceuticals, Inc. Names Chittima Sirijerachai, MD as Principal Investigator for Upcoming AML Clinical Trials View Release http://www.richpharmaceuticals.com/wp-content/uploads/2015/03/Press-Releases-3_12_15-PI-Investigator-for-Rich-Pharma.pdf